https://orcid.org/0000-0002-2512-6131
Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Haohao Chen, Yanyan Liu, Zhenglang Yin, Hao Chen, Yao Wang & Yeben Qian. (2023) Homologous repair deficiency-associated genes in invasive breast cancer revealed by WGCNA co-expression network analysis and genetic perturbation similarity analysis. Cell Cycle 22:9, pages 1077-1100.
Read now
Read now
Martina Catalano, Luigi Francesco Iannone, Federica Cosso, Daniele Generali, Enrico Mini & Giandomenico Roviello. (2022) Combining inhibition of immune checkpoints and PARP: rationale and perspectives in cancer treatment. Expert Opinion on Therapeutic Targets 26:11, pages 923-936.
Read now
Read now
Arpit Rao & Emmanuel S. Antonarakis. (2022) The growing role of rucaparib in contemporary treatment of metastatic prostate cancer: a review of efficacy and guidance for side effect management. Expert Review of Anticancer Therapy 22:7, pages 671-679.
Read now
Read now
Yun Dai, Munawaer Muaibati, Weiming Xie, Abuduyilimu Abasi, Kexin Li, Qing Tong, Tao Zhang, Yifan Meng, Liang Zhuang & Xiaoyuan Huang. (2022) PD-1/PD-L1 Inhibitors Monotherapy for the Treatment of Endometrial Cancer: Meta-Analysis and Systematic Review. Cancer Investigation 40:3, pages 293-309.
Read now
Read now
Tao Wang, Lei Dong, Juanjuan Sun, Jialiang Shao, Jian Zhang, Siteng Chen, Chaofu Wang, Gangfeng Wu & Xiang Wang. (2021) miR-145-5p: A Potential Biomarker in Predicting Gleason Upgrading of Prostate Biopsy Samples Scored 3+3=6. Cancer Management and Research 13, pages 9095-9106.
Read now
Read now
Articles from other publishers (30)
Haixia Liu, Xiaohui Chen, Yimin Jia, Hengyi Chen, Xiaohui Wang, Guoxiang Liu & Yang Luo. (2023) Facing inevitable PARPis resistance: Mechanisms and therapeutic strategies for breast cancer treatment. Interdisciplinary Medicine 1:2.
Crossref
Crossref
Shuaijun Ma, Yafan Chen, Penghe Quan, Jingliang Zhang, Shichao Han, Guohui Wang, Ruochen Qi, Xiaoyan Zhang, Fuli Wang, Jianlin Yuan, Xiaojian Yang, Weijing Jia & Weijun Qin. (2023) NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling. BMC Cancer 23:1.
Crossref
Crossref
Beatrice Gadiel Mathew, Fine Aliyuda, Denis Taiwo, Kehinde Adekeye, Godwin Agada, Elisabet Sanchez, Aruni Ghose, Elie Rassy & Stergios Boussios. (2023) From Biology to Diagnosis and Treatment: The Ariadne’s Thread in Cancer of Unknown Primary. International Journal of Molecular Sciences 24:6, pages 5588.
Crossref
Crossref
Giuseppa Zannini, Gaetano Facchini, Marco De Sio, Ferdinando De Vita, Andrea Ronchi, Michele Orditura, Maria Teresa Vietri, Fortunato Ciardiello, Renato Franco, Marina Accardo & Federica Zito Marino. (2023) Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types. Pathology - Research and Practice 243, pages 154336.
Crossref
Crossref
Honghui Zhu, Yi Ding, Hang Huang, Qi Lin, Wei Chen & Zhixian Yu. (2023) Prognostic value of genomic mutations in metastatic prostate cancer. Heliyon 9:3, pages e13827.
Crossref
Crossref
Anmol Bhatia, Atul Kumar Upadhyay & Siddharth Sharma. (2022)
miRNAs
are now starring in “
No Time to Die
: Overcoming the chemoresistance in cancer”
. IUBMB Life 75:3, pages 238-256.
Crossref
Crossref
Qian Yi, Jianguo Feng, Yi Liao & Weichao Sun. (2022)
Circular
RNAs
in chemotherapy resistance of lung cancer and their potential therapeutic application
. IUBMB Life 75:3, pages 225-237.
Crossref
Crossref
Stergios Boussios & Matin Sheriff. (2023) Aberrations of DNA Repair Pathways in Prostate Cancer—The State of the Art. International Journal of Molecular Sciences 24:5, pages 4301.
Crossref
Crossref
Abolghasem Allahyari, Amirhosein Maharati, Amir Masoud Jafari-Nozad & Alireza zangooie. (2023) Prostate cancer, chronic myelogenous leukemia and multiple myeloma in a single patient: a case report and review of the literature. Journal of Medical Case Reports 17:1.
Crossref
Crossref
Floriane Jochum, Martina Aida Angeles, Vincent Balaya, Leonor Drouin, Tanja Nikolova, Patrice Mathevet, Fabrice Lécuru, Henri Azais, Sarah Betrian, Pierre-Adrien Bolze, Yohann Dabi, Yohan Kerbage, Claire Sanson, François Zaccarini, Fréderic Guyon, Cherif Akladios, Arthur Hsu, Sofiane Bendifallah, Elise Deluche & Benedetta Guani. (2023) Management of patients with advanced epithelial ovarian cancer: a European survey. Archives of Gynecology and Obstetrics.
Crossref
Crossref
Martina Catalano, Daniele Generali, Marta Gatti, Barbara Riboli, Leda Paganini, Gabriella Nesi & Giandomenico Roviello. (2023) DNA repair deficiency as circulating biomarker in prostate cancer. Frontiers in Oncology 13.
Crossref
Crossref
Xiaofeng Cheng, Zhenhao Zeng, Heng Yang, Yujun Chen, Yifu Liu, Xiaochen Zhou, Cheng Zhang & Gongxian Wang. (2023) Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma. BMC Cancer 23:1.
Crossref
Crossref
Jingcao Zheng, Zhengyu Li & Wenjiao Min. (2023) Current status and future promise of next-generation poly (ADP-Ribose) polymerase 1-selective inhibitor AZD5305. Frontiers in Pharmacology 13.
Crossref
Crossref
Yongsong Wu, Shilin Xu, Shanshan Cheng, Jiani Yang & Yu Wang. (2023) Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status. Journal of Ovarian Research 16:1.
Crossref
Crossref
Carolina Bezzi, Alice Bergamini, Gregory Mathoux, Samuele Ghezzo, Lavinia Monaco, Giorgio Candotti, Federico Fallanca, Ana Maria Samanes Gajate, Emanuela Rabaiotti, Raffaella Cioffi, Luca Bocciolone, Luigi Gianolli, GianLuca Taccagni, Massimo Candiani, Giorgia Mangili, Paola Mapelli & Maria Picchio. (2023) Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness. Cancers 15:1, pages 325.
Crossref
Crossref
Jianguo Wang, Shizhong Cai, Qianwei Xiong, Deyu Weng, Qian Wang & Zhourui Ma. (2022) PIK3R2 predicts poor outcomes for patients with melanoma and contributes to the malignant progression via PI3K/AKT/NF-κB axis. Clinical and Translational Oncology 25:5, pages 1402-1412.
Crossref
Crossref
Yuan Bian, Ping Guan, Dan Li, Longjing Tan, Haowen Pang, Qinglian Wen, Ping Chen & Zhenhua Zhang. (2022) Interstitial brachytherapy combined with PARP inhibitors in the treatment of chemoresistant recurrent epithelial ovarian cancer: A case report. Frontiers in Oncology 12.
Crossref
Crossref
Bulent Cetin, Chiara A Wabl & Ozge Gumusay. (2022) Should one use the combination of abiraterone and poly(ADP-ribose) polymerase inhibitors as first-line therapy for all patients with metastatic castration-resistant prostate cancer?. Future Oncology 18:39, pages 4235-4238.
Crossref
Crossref
Hiroko Kimura, Kei Mizuno, Masaki Shiota, Shintaro Narita, Naoki Terada, Naohiro Fujimoto, Keiji Ogura, Shotaro Hatano, Yusuke Iwasaki, Nozomi Hakozaki, Satoshi Ishitoya, Takayuki Sumiyoshi, Takayuki Goto, Takashi Kobayashi, Hidewaki Nakagawa, Toshiyuki Kamoto, Masatoshi Eto, Tomonori Habuchi, Osamu Ogawa, Yukihide Momozawa & Shusuke Akamatsu. (2022) Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer. British Journal of Cancer 127:9, pages 1680-1690.
Crossref
Crossref
Aruni Ghose, Anita Bolina, Ishika Mahajan, Syed Ahmer Raza, Miranda Clarke, Abhinanda Pal, Elisabet Sanchez, Kathrine Sofia Rallis & Stergios Boussios. (2022) Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy. International Journal of Environmental Research and Public Health 19:19, pages 12057.
Crossref
Crossref
Xin Sun, Wenjuan Chen, Xiujuan Qu & Ying Chen. (2022) Case Report: Fluzoparib for multiple lines of chemotherapy refractory in metastatic cutaneous squamous cell carcinoma with BRCA2 pathogenic mutation. Frontiers in Pharmacology 13.
Crossref
Crossref
Stergios Boussios, Elie Rassy, Michele Moschetta, Aruni Ghose, Sola Adeleke, Elisabet Sanchez, Matin Sheriff, Cyrus Chargari & Nicholas Pavlidis. (2022) BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside. Cancers 14:16, pages 3888.
Crossref
Crossref
Antonios Revythis, Anu Limbu, Christos Mikropoulos, Aruni Ghose, Elisabet Sanchez, Matin Sheriff & Stergios Boussios. (2022) Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer. International Journal of Environmental Research and Public Health 19:14, pages 8577.
Crossref
Crossref
Sidrah Shah, Alison Cheung, Mikolaj Kutka, Matin Sheriff & Stergios Boussios. (2022) Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes. International Journal of Environmental Research and Public Health 19:13, pages 8113.
Crossref
Crossref
Sola Adeleke, Aidan Haslam, Adrian Choy, Salvador Diaz-Cano, Joao R Galante, Christos Mikropoulos & Stergios Boussios. (2022) Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls. Personalized Medicine 19:4, pages 277-286.
Crossref
Crossref
Helen Saxby, Stergios Boussios & Christos Mikropoulos. (2022) Androgen Receptor Gene Pathway Upregulation and Radiation Resistance in Oligometastatic Prostate Cancer. International Journal of Molecular Sciences 23:9, pages 4786.
Crossref
Crossref
Sidrah Shah, Rachelle Rachmat, Synthia Enyioma, Aruni Ghose, Antonios Revythis & Stergios Boussios. (2021) BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations. International Journal of Molecular Sciences 22:23, pages 12628.
Crossref
Crossref
Kit Man Chan, Jonathan M. Gleadle, Philip A. Gregory, Caroline A. Phillips, Hanieh Safizadeh Shirazi, Amelia Whiteley, Jordan Li, Krasimir Vasilev & Melanie MacGregor. (2021) Selective Microfluidic Capture and Detection of Prostate Cancer Cells from Urine without Digital Rectal Examination. Cancers 13:21, pages 5544.
Crossref
Crossref
Evangelia Ioannidou, Michele Moschetta, Sidrah Shah, Jack Steven Parker, Mehmet Akif Ozturk, George Pappas-Gogos, Matin Sheriff, Elie Rassy & Stergios Boussios. (2021) Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets. International Journal of Molecular Sciences 22:18, pages 9926.
Crossref
Crossref
Aruni Ghose, Michele Moschetta, George Pappas-Gogos, Matin Sheriff & Stergios Boussios. (2021) Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the Clinic. International Journal of Molecular Sciences 22:18, pages 9783.
Crossref
Crossref